The Subcommittee on Regulatory Reform, Commercial and Antitrust Law consists of 10 members, representing both parties, and has jurisdiction over, “bankruptcy and commercial law, bankruptcy judgeships, administrative law, independent counsel, state taxation affecting interstate commerce, interstate compacts, antitrust matters, other appropriate matters as referred by the Chairman, and relevant oversight.”
More on Regulatory Reform
Washington, D.C. - This week, Congressman Tom Marino (PA-10) introduced H.R. 5468, the Permitting Litigation Efficiency Act and held a hearing on the legislation as Chairman in the Subcommittee on Regulatory Reform, Commercial and Antitrust Law.
Washington, D.C. – Congressman Tom Marino (PA-10) issued the following statement regarding President Trump’s proclamation authorizing tariffs on imported steel and aluminum:
Washington, D.C.—Tomorrow at 1:00 p.m. Congressman Tom Marino (PA-10) will hold a hearing on anticompetitive behavior and the health care marketplace.
Washington, D.C.--Today, the U.S. Food and Drug Administration (FDA) held a public meeting to solicit input in areas where the FDA’s rules are being used in ways that create obstacles and delays. FDA Commissioner Scott Gottlieb, M.D., has shown a commitment to ensuring that generic manufacturers have access to promote competition.
Washington D.C.—Congressman Tom Marino (PA-10) issued the following statement following the Trump administration’s withdrawal of the Waters of the United States rule, commonly referred to as WOTUS.
Washington, D.C. — On Wednesday, the House passed H.R. 5, the Regulatory Accountability Act of 2017, a reform to solve the problem of overreaching, ill-considered, insufficiently checked-and-balanced federal regulation. It brings together six separate reform bills that have already passed the House with bipartisan support in previous Congresses.
Washington D.C. – Last night, the U.S. House of Representatives passed H.R. 26, the Regulations from the Executive in Need of Scrutiny Act of 2017, which requires an up-or-down vote by Congress before any new regulation with at least a $100 million effect on the economy can be implemented.
Rep. Tom Marino (PA-10) released the following statement:
Washington D.C. – Rep. Tom Marino released the following statement after the U.S. House of Representatives passed H.R. 21, the Midnight Rules Relief Act:
Washington D.C. – Rep. Tom Marino released the following statement after reintroducing the REVIEW Act on the first day of the 115th Congress:
Washington, D.C. — The House Judiciary Committee today approved the “Require Evaluation before Implementing Executive Wishlists Act of 2015 (REVIEW Act)” (H.R. 3438) by a vote of 18-13.